Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion
E Lipšic, P van der Meer, RH Henning… - Journal of …, 2004 - journals.lww.com
Erythropoietin (EPO) is a hormone known to stimulate hematopoiesis. However, recent
research suggests additional properties of EPO, such as protection against …
research suggests additional properties of EPO, such as protection against …
[HTML][HTML] Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart
Recent studies from our lab and others have shown that the hematopoietic cytokine
erythropoietin (EPO) can protect the heart from ischemic damage in a red blood cell …
erythropoietin (EPO) can protect the heart from ischemic damage in a red blood cell …
Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo
AJ Bullard, P Govewalla, DM Yellon - Basic research in cardiology, 2005 - Springer
Objective Erythropoietin (EPO) is a hormone that is currently used to treat patients with renal
failure and anaemia. However, it has also been shown to protect against …
failure and anaemia. However, it has also been shown to protect against …
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia‐reperfusion injury
P van der Meer, E Lipsic, RH Henning… - European Journal of …, 2004 - Wiley Online Library
Background: Recent studies show that erythropoietin (EPO) plays a protective role in brain
ischemia. In this condition, administration of EPO protects neurons from ischemic damage …
ischemia. In this condition, administration of EPO protects neurons from ischemic damage …
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts
A Hirata, T Minamino, H Asanuma, S Sanada… - … drugs and therapy, 2005 - Springer
Although recent studies suggest that erythropoietin (EPO) may reduce multiple features of
the myocardial ischemia/reperfusion injury, the cellular mechanisms and the clinical …
the myocardial ischemia/reperfusion injury, the cellular mechanisms and the clinical …
Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear …
B Xu, G Dong, H Liu, Y Wang, H Wu… - Annals of Clinical & …, 2005 - Assoc Clin Scientists
Erythropoietin (EPO), known for its role in stimulating erythropoiesis, has recently been
shown to have a cardio-protective effect in animal models of myocardial ischemia …
shown to have a cardio-protective effect in animal models of myocardial ischemia …
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside
E Lipšic, RG Schoemaker, P van der Meer… - Journal of the American …, 2006 - jacc.org
Erythropoietin (EPO) is a hypoxia-induced hormone produced in the kidneys that stimulates
hematopoiesis in the bone marrow. However, recent studies have also shown important …
hematopoiesis in the bone marrow. However, recent studies have also shown important …
Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window
C Moon, M Krawczyk, D Paik, EG Lakatta… - … drugs and therapy, 2005 - Springer
Background: Recombinant human erythropoietin (rhEPO) protects tissue from ischemic
damage, but translation of this finding into useful guidelines with respect to human trials for …
damage, but translation of this finding into useful guidelines with respect to human trials for …
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
L Calvillo, R Latini, J Kajstura, A Leri… - Proceedings of the …, 2003 - National Acad Sciences
Erythropoietin (EPO), originally identified for its critical hormonal role in promoting
erythrocyte survival and differentiation, is a member of the large and diverse cytokine …
erythrocyte survival and differentiation, is a member of the large and diverse cytokine …
An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection
MA Bogoyevitch - Cardiovascular research, 2004 - academic.oup.com
Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …